Dietary therapy of the herbal porridge improves the symptoms of functional dyspepsia: A randomized, double-blind, placebo-controlled, clinical trial.
Xin WangMeng-Ao LiuJia HeWen-Zhi ZhaoYi-Xuan WangLiu-Qing YangTian-Yuan WangHan-Ping ShiBen-Qiang RaoPublished in: Food science & nutrition (2024)
This study (ISRCTN17174559) aimed to explore the efficacy and safety of a kind of herbal porridge (Hou Gu Mi Xi) on the clinical symptoms of functional dyspepsia (FD). This was a single-center, single-dose, prospective, double-blind, randomized controlled trial involving 64 participants with FD (35 cases and 29 controls) for 2 months of intervention and 1 month of follow-up. The 7-point Global Overall Symptom Scale (GOSS), 36-Item Short Form Survey (SF-36), and other indicators were assessed at baseline (day 0), at days 15, 30, and 60 of treatment, and at follow-up 1 month after the end of the intervention. Many participants with FD achieved remission of their epigastric symptoms at follow-up on the 90th day after treatment with herbal porridge compared to the placebo group (45.71% vs. 20.69%, p = .036). Furthermore, herbal porridge appeared to be effective in improving the quality of life of participants with FD, which was reflected in the rising SF-36 scores for physical role, bodily pain, emotional role, and mental health. Although adverse events were reported, there was no overall difference in the number of adverse events between the two groups ( p = .578). Herbal porridge is another effective and safe method for improving the symptoms and quality of life in patients with FD.
Keyphrases
- double blind
- placebo controlled
- randomized controlled trial
- clinical trial
- study protocol
- mental health
- phase iii
- phase ii
- sleep quality
- open label
- chronic pain
- depressive symptoms
- phase ii study
- systemic lupus erythematosus
- squamous cell carcinoma
- smoking cessation
- irritable bowel syndrome
- bone marrow
- neuropathic pain
- mental illness